Roger O. McClellan

Alterations in particle accumulation and clearance in lungs of rats chronically exposed to diesel exhaust

F344 rats were chronically exposed to diesel exhaust at target soot concentrations of 0 (control, C), 0.35 (low, L), 3.5 (medium, M), and 7.0 (high, H) mg/m3. Accumulated lung burdens of diesel soot were measured after 6, 12, 18, and 24 months of exposure. Parallel measurements of particle deposition and clearance were made to provide insight into the mechanisms of particle accumulation in lungs. The fractional deposition of inhaled 67Ga2O3 particles after 6, 12, 18, and 24 months of exposure and of inhaled 134Cs-fused aluminosilicate particles after 24 months were similar for all groups. Progressive increases in lung burdens of soot particles were observed in M and H exposed rats, reaching levels of 11.5 +/- 0.5 and 20.5 +/- 0.8 mg/lung (mean +/- SE), respectively, after 24 months. Rats in the L group had smaller relative increases in lung burden, reaching levels of 0.60 +/- 0.02 mg/lung after 24 months. Tracheal mucociliary clearance measurements, using 99mTc-macroaggregated albumin deposited in the trachea, showed no changes at anytime. There were statistically significant increases in clearance half-times of inhaled radiolabeled particles of 67Ga2O3 as early as 6 months at the H level and 18 months at the M level; no significant changes were seen at the L level. Rats inhaled fused aluminosilicate particles labeled with 134Cs after 24 months of diesel exhaust exposure to measure long-term components of pulmonary clearance. The long-term clearance half-times were 79 +/- 5, 81 +/- 5, 264 +/- 50, and 240 +/- 50 days (mean +/- SE) for the C, L, M, and H groups, respectively. Differences were significant between the C and both the M and H exposure groups (p less than 0.01). Lung burdens of diesel soot were more than expected at the H and M levels and were also associated with impaired particle clearance while smaller responses were observed in both burdens and clearance at the L level.

Pulmonary Retention and Clearance of Inhaled Biopersistent Aerosol Particles: Data-Reducing Interpolation Models and Models of Physiologically Based Systems: - A Review of Recent Progress and Remaining Problems

During the last 40 years, most models of long-term clearance and retention of biopersistent particles in the pulmonary region of the lung were phenomenologically oriented and accounted for only a small portion of the growing insight into lung dynamics by pulmologists, histologists, and biochemists. In this review, theoretical developments of modeling pulmonary dynamics for biopersistent particles during or after inhalation exposure are discussed. Several characteristic examples are given of the present state of the art. Most of the models presently in use are pragmatical compartmental models with a single compartment for the pulmonary region. They relate to observed data and facilitate an interpolation within the range covered by observation. Occasionally, these models are unjustifiably used for extrapolations in efforts to derive hypothetical risk assessments. Modeling efforts aiming at models of physiologically based pulmonary systems with a potential for extrapolations are not common and were published only during the last decade. Of this kind of approach, the review covers four examples. Promising progress has been made, but scarcity of supporting experimental data slows validation and extension. The two most recent model developments are based on a hypothesis by P.E. Morrow. According to Morrow, alveolar clearance is accomplished by mobile alveolar macrophages after phagocytosis of particles on the alveolar surface. The macrophage mobility, however, and thus the efficiency of the transport to the mucociliary escalator of the tracheobronchial tract will eventually decline towards total loss of mobility after the particle burden of the macrophages exceeds a critical value. The POCK model has been evaluated for a variety of chronic and subchronic rat exposure studies with noncytotoxic aerosols and gave good simulation results. The model by Tran et al. appears to be still in the developing stage of facilitating simulations for cytotoxic aerosols, but the combination of both model approaches seems to be a sound route of future efforts.

KEYNOTE ADDRESS: HUMAN HEALTH RISK ASSESSMENT: A Historical Overview and Alternative Paths Forward

Risk assessment has become a more structured activity during the past 50 years and increasingly is being used to inform major policy decisions. Much use has been made of the hazard identification phase of risk assessment to identify potentially hazardous materials or situations and guide actions to minimize potential risks. Much less frequently the process has been carried further, with estimates developed of the potency of the hazardous agent for causing adverse effects. And even less frequently, robust estimates of exposure have been developed. Thus, in only a few instances have risks been fully characterized in quantitative terms for either individuals or populations. To develop scientifically valid risk characterizations for many chemicals, much more scientific information must be acquired in a targeted manner to establish the potency of chemicals for causing cancer or other adverse health effects. Similar substantial effort must also be applied to characterizing the exposure populations receive from specific chemicals released from various source categories. In the absence of these scientifically rigorous approaches it is likely that societal actions will be guided primarily by identification of potential hazardous agents, with attempts made to minimize the hazard by banning or restricting use of the agent. This precautionary approach may not yield the maximum reduction in health risks to society for the investments made and, in addition, may deny society access to materials or processes that under appropriate conditions of use would not result in significant health risks and may indeed, have substantial net benefits to society.

Critical considerations in evaluating scientific evidence of health effects of ambient ozone: A conference report

The U.S. Environmental Protection Agency (EPA), under the authority of the Clean Air Act (CAA), is required to promulgate National Ambient Air Quality Standards (NAAQSs) for criteria air pollutants, including ozone. Each NAAQS includes a primary health-based standard and a secondary or welfare-based standard. This paper considers only the science used for revision of the primary standard for ozone in 2008. This paper summarizes deliberations of a small group of scientists who met in June 2007 to review the scientific information informing the EPA Administrator’s proposed revision of the 1997 standard. The Panel recognized that there is no scientific methodology that, in the absence of judgment, can define the precise numerical level, related averaging time, and statistical form of the NAAQS. The selection of these elements of the NAAQS involves policy judgments that should be informed by scientific information and analyses. Thus, the Panel members did not feel it appropriate to offer either their individual or collective judgment on the specific numerical level of the NAAQS for ozone. The Panel deliberations focused on the scientific data available on the health effects of exposure to ambient concentrations of ozone, controlled ozone exposure studies with human volunteers, long-term epidemiological studies, time- series epidemiological studies, human panel studies, and toxicological investigations. The deliberations also dealt with the issue of background levels of ozone of nonanthropogenic origin and issues involved with conducting formal risk assessments of the health impacts of current and prospective levels of ambient ozone. The scientific issues that were central to the EPA Administrator’s 2008 revision of the NAAQS for ozone will undoubtedly also be critical to the next review of the ozone standard. That review should begin very soon if it is to be completed within the 5-year cycle specified in the CAA. It is hoped that this Report will stimulate discussion of these scientific issues, conduct of additional research, and conduct of new analyses that will provide an improved scientific basis for the policy judgment that will have to be made by a future EPA Administrator in considering potential revision of the ozone standard.

Toxicity of lunar dust assessed in inhalation-exposed rats

Abstract Humans will again set foot on the moon. The moon is covered by a layer of fine dust, which can pose a respiratory hazard. We investigated the pulmonary toxicity of lunar dust in rats exposed to 0, 2.1, 6.8, 20.8 and 60.6 mg/m3 of respirable-size lunar dust for 4 weeks (6 h/day, 5 days/week); the aerosols in the nose-only exposure chambers were generated from a jet-mill ground preparation of a lunar soil collected during the Apollo 14 mission. After 4 weeks of exposure to air or lunar dust, groups of five rats were euthanized 1 day, 1 week, 4 weeks or 13 weeks after the last exposure for assessment of pulmonary toxicity. Biomarkers of toxicity assessed in bronchoalveolar fluids showed concentration-dependent changes; biomarkers that showed treatment effects were total cell and neutrophil counts, total protein concentrations and cellular enzymes (lactate dehydrogenase, glutamyl transferase and aspartate transaminase). No statistically significant differences in these biomarkers were detected between rats exposed to air and those exposed to the two low concentrations of lunar dust. Dose-dependent histopathology, including inflammation, septal thickening, fibrosis and granulomas, in the lung was observed at the two higher exposure concentrations. No lesions were detected in rats exposed to ≤6.8 mg/m3. This 4-week exposure study in rats showed that 6.8 mg/m3 was the highest no-observable-adverse-effect level (NOAEL). These results will be useful for assessing the health risk to humans of exposure to lunar dust, establishing human exposure limits and guiding the design of dust mitigation systems in lunar landers or habitats.

Risk assessment and biological mechanisms: lessons learned, future opportunities

During the past decade, toxicological research has been dominated by two themes; investigations to elucidate the mechanisms of action of toxicants and studies to provide information to support improved assessments of human health risks. The conduct of mechanistic investigations was given an early impetus by advances in biochemistry and cell biology and, more recently, by related advances in molecular biology. Research to provide information for improved human health risk assessments was stimulated by the 1983 NAS/NRC report that provided a codified structure for conducting risk assessments. At first glance, it would appear that the two themes are closely related and, indeed, should represent parts of a joined theme. However, examination of the toxicology/risk assessment literature of the past decade indicates that this has not been the case. Reports of mechanistic studies infrequently indicate how the information can be used to provide improved estimates of human risk from exposure to toxicants. If reference is made, it is usually qualitative in nature. Neither is examination of the risk assessment literature reassuring. Mechanistic studies may be cited; however, the final step of the process, risk characterization, is usually dominated by the use of default options grounded in conservative interpretations of generic scientific knowledge. Two examples are reviewed that stand out as illustrations of how mechanistic information can be used to make a difference in risk assessments: (1) consideration of the alpha 2u-globulin-mediated mechanism for evaluating male rat data for relevance in assessing human risks of renal cancer and (2) the use of DNA-protein cross-links as an internal dose metric in cross-species extrapolation of nasal cancer risks from inhaled formaldehyde. This paper reviews past experience on these topics and suggests a strategy for increasing the use of mechanistic information in risk assessments. A key component of the strategy is to use the risk assessment process to identify research needs/opportunities that, if addressed, will reduce the use of default options, thereby reducing the uncertainties in risk assessments. Another component of the strategy is to identify a few chemicals anticipated to exert their effect via different mechanisms and whose mechanisms of dosimetry and disease pathogenesis can be investigated in-depth within a risk assessment framework; this identification will create prototype approaches as alternatives to the use of default options that have major impact on the outcome of the risk assessment process.

Reducing Uncertainty in Risk Assessment by Using Specific Knowledge to Replace Default Options

This paper has advocated the development of specific scientific information, especially information on the mechanisms of action of chemicals, to use in place of default options in assessing human cancer risks. Four examples have been discussed that build largely on information from the CIIT research program. These four examples are worthy of consideration as a group, with a view to developing insights for increasing the effectiveness and efficiency of obtaining such data in the future and, most of all, to increase their acceptance for use instead of default options. In my view, key features of all four examples are that the data are framed within an exposure-dose-response paradigm and that there is a clear linkage to the end point of concern-cancer. As the number of techniques available for making observations at the cellular and molecular levels continues to increase at a rapid pace, linking these observations to the health end points of concern such as cancer is going to be increasingly important, especially in enhancing the value of the observations for risk assessment purposes. Equally as important, the mechanistic observations must be linked to realistic exposures and associated tissue dose that can be related to realistic human exposure scenarios. In my opinion, the likelihood of obtaining information of value for risk assessment purposes using the most sophisticated of molecular and cellular techniques will be of limited value if the exposures or doses are not realistically linked to those likely to be encountered by humans. The mechanism of alpha 2u-globulin nephropathy and its association with kidney tumors in male rats and the conclusion that the male rat kidney tumor findings are not applicable to assessing human cancer risk is an example of a qualitative decision. I suspect this may be a somewhat unusual case. As one looks across the various mammalian species used for experimentation and makes comparisons with humans, a unifying theme is the relative abundance of similarities. Indeed, this is a major argument for the use of laboratory animals to obtain information relevant to humans. Nonetheless, vigilance to differences among species is important. When differences are observed, we must capitalize on them to better understand the underlying biological mechanisms that mediate the differences. If, as I have suggested, laboratory animal species are more like than different from humans in their basic biological characteristics, there is a rationale for continuing to use laboratory animals as sources of data to help assess human risks of exposure to chemicals. It follows from this that quantitative differences among species such as observed with both formaldehyde and 1,3-butadiene assume major importance for assessing human risks. In my opinion, quantitation of the likely human carcinogenic potency of chemicals is of major importance. It is not sufficient to simply classify chemicals with regard to the likelihood of their being human carcinogens, as done by IARC (1994) and U.S. EPA (1986). IARC has placed more than 60 chemicals or processes (such as coke production) in group 1, carcinogenic to humans; more than 50 in group 2a, probably carcinogenic to humans; and 250 in group 2b, possibly carcinogenic to humans. This rank order implies differing levels of concern for three categories. However, even this rough three-bin system does not convey a very clear picture as to the degree of concern that should be accorded a given chemical for producing cancer. For example, the chemicals categorized as group 1, human carcinogens, using potency estimates developed by the U.S. EPA differ in potency by roughly 4 orders of magnitude. For example, a lifetime cancer risk is 6.2 x 10(-2) per micrograms/m3 for bischloromethyl ether and 8.3 x 10(-6) for benzene (NRC, 1994). Differences such as this offer strong arguments for complementing simplistic hazard identification schemes such as the IARC and EPA carcinogen classification systems w

Studies on the ability of rat lung and liver microsomes to facilitate transfer and metabolism of benzo[a]pyrene from diesel particles

Little is known about the bioavailability of inhaled organic compounds that are associated with particles. It is known that certain particle-associated organic compounds, such as polycyclic aromatic hydrocarbons (PAH) adsorbed on diesel soot particles, are retained in the lung longer than PAH inhaled in pure form. If such particle-associated compounds are available for tissue interaction, their prolonged retention may result in an increased potential for a toxic effect. To determine the factors affecting the bioavailability of particle-associated PAH, we have studied the ability of microsomes to facilitate transfer of benzo[a]pyrene (B[a]P) adsorbed on the surface of diesel exhaust soot particles to the microsomes and the ability of the microsomes to metabolize the transferred B[a]P. Our results indicate that rat lung and liver microsomes were able to facilitate the transfer of small amounts of B[a]P from diesel particles (less than 3%), but only a fraction of the amount transferred (1-2%) was metabolized. Under the same incubation conditions without soot, free B[a]P was extensively metabolized by microsomes, principally to B[a]P-9,10-diol. Lung microsomes were about twice as effective as liver microsomes for the transfer of the B[a]P. The ability to transfer B[a]P to the microsomes was independent of metabolism or the presence of protein, but was related to the lipid content of the microsomal fraction. There was no metabolism of the B[a]P coated on diesel particles as analyzed by high-performance liquid chromatography. These findings suggest that microsomes are able to enhance the slow transfer of only a small amount of B[a]P from diesel particles in a form that can be metabolized. However, over a long period of time, this slow release might be significant.

Pulmonary Carcinogenesis and Chronic Beta Irradiation of Lung

Light water nuclear power reactor fuel cycles at various stages contain substantial quantities of β-emitting radionuclides. Thus, in the event of an accident, there is potential for inhalation exposure of man to various types and forms of β-emitting radionuclides. In order to study the biological effects of such potential exposures, a series of life span studies have been initiated in which beagle dogs have been exposed to inhalation to achieve graded lung burdens of a relatively insoluble fused clay form of β-emitting radionuclides. The specific radionuclides, 90Y, 91Y, 144Ce, or 90Sr, were selected on the basis of physical half-life to produce a variety of radiationdose patterns to the lung. Early effects have been the development of radiation pneumonitis and progressive pulmonary fibrosis. In general, dogs which receive high- and rapidly-declining dose-rate exposure from 90Y or 91Y die earlier and at lower cumulative doses than dogs exposed to 144Ce or 90Sr. By contrast, the incidence of later-occurring malignant lung tumors and the degree of inflammatory response is greater in dogs which received protracted low dose-rate exposure associated with 144Ce and 90Sr. Of particular note is the nature of the lung tumors thus far observed. These have been of endothelial origin — hemangiosarcomas rather than the epithelial carcinomas that are seen in uranium miners or dogs exposed to 239PuO2. This association between β-radiation exposure and vascular neoplasms will be discussed further.

LUNG CANCER IN RATS FROM PROLONGED EXPOSURE TO HIGH CONCENTRATIONS OF CARBONACEOUS PARTICLES: IMPLICATIONS FOR HUMAN RISK ASSESSMENT

High incidences of lung cancers have been observed in a number of studies in which rats were chronically exposed by inhalation to high concentrations of diesel engine exhaust and carbon black particles. These particles have previously been viewed as being relatively innocuous compared with other particles such as benzo[a]pyrene that are carcinogenic because of specific chemical properties. Studies with mice and Syrian hamsters exposed to similar concentrations of diesel exhaust did not produce an excess of lung cancer or yielded equivocal outcomes. Diesel exhaust soot and carbon black particles are readily inhaled and deposited in the pulmonary region, where they are retained with a long half-life because of their low solubility. Substantial evidence indicates that the increased incidence of rat lung cancers results from the accumulation of large burdens of particles in the lungs, altered clearance of particles from the lungs, persistent inflammation, increased cell turnover, and induction of mutations in...